Maternal Cannabis Use During Pregnancy and Neuropsychiatric Adverse Outcomes During Childhood and Early Adult Life

被引:0
|
作者
Andrade, Chittaranjan [1 ,2 ]
机构
[1] Manipal Acad higher Educ, Kasturba Med Coll, Dept Psychiat, Manipal, India
[2] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychopharmacol & Neurotoxicol, Bangalore, India
关键词
D O I
10.4088/JCP.24f15753
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Cannabis use during pregnancy is increasing; the study of adverse outcomes in cannabis-exposed pregnancies is therefore important. Previous articles in this series described increased risks of maternal adverse outcomes, fetal adverse outcomes, birth defects in newborns, and autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in childhood. This article examines neuropsychiatric adverse outcomes in offspring gestationally exposed to cannabis. Currently available research suggests that prenatal cannabis exposure is associated with increased risks of ASD, ADHD, psychosis proneness, psychotic- like experiences, internalizing problems, externalizing problems, attention problems, thought-related problems, social problems, impaired executive function, and observed aggression. There is insufficient study of prenatal cannabis exposure and offspring IQ. Shortcomings in the existing literature are discussed; as examples, many outcomes were determined by screening rather than by formal assessment, prenatal cannabis exposure was ascertained retrospectively in some studies, childhood adverse experiences and exposures were seldom included as covariates, and details about cannabis use (source, potency, frequency, reasons) were unavailable. Curiously, the findings of adverse outcomes were inconsistent, and the effect sizes were small. Possible explanations are that women who use cannabis during pregnancy may not admit it and their pregnancy outcomes may then be misclassified into the control group, assessment of outcomes at too young an age or with insufficient accuracy may blur differences between exposed and unexposed groups, and adjustment for covariates may mask the full effects of cannabis. A last observation is that the studies reviewed were based on exposures that occurred decades ago. Given the increasing potency of currently available cannabis and the limitations of the existing research, it is possible that the available findings underestimate the breadth and severity of the risks. Cannabis is not a necessary substance for use during pregnancy, and so women who consider it safe might do well to guard against complacency and unnecessary exposure.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [41] Intranasal Triamcinolone Use during Pregnancy and the Risk of Adverse Pregnancy Outcomes
    Berard, A. B.
    Sheehy, O. S.
    Kurzinger, M. L. K.
    Juhaeri, J. J.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2015, 103 (05) : 410 - 410
  • [42] Intranasal Triamcinolone Use during Pregnancy and the Risk of Adverse Pregnancy Outcomes
    Berard, Anick
    Sheehy, Odile
    Kurzinger, Marie-Laure
    Juhaeri, Juhaeri
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 255 - 255
  • [43] Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review
    Hanan El Marroun
    Tonya White
    Frank C. Verhulst
    Henning Tiemeier
    European Child & Adolescent Psychiatry, 2014, 23 : 973 - 992
  • [44] Maternal cannabis use in pregnancy and child neurodevelopmental outcomes
    Daniel J. Corsi
    Jessy Donelle
    Ewa Sucha
    Steven Hawken
    Helen Hsu
    Darine El-Chaâr
    Lise Bisnaire
    Deshayne Fell
    Shi Wu Wen
    Mark Walker
    Nature Medicine, 2020, 26 : 1536 - 1540
  • [45] Association of Beverage Consumption during Pregnancy with Adverse Maternal and Offspring Outcomes
    Wang, Zhengyuan
    Cui, Xin
    Yu, Huiting
    Chan, Ee-Mien
    Shi, Zehuan
    Shi, Shuwen
    Shen, Liping
    Sun, Zhuo
    Song, Qi
    Lu, Wei
    Ma, Wenqing
    Mai, Shupeng
    Zang, Jiajie
    NUTRIENTS, 2024, 16 (15)
  • [46] Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review
    El Marroun, Hanan
    White, Tonya
    Verhulst, Frank C.
    Tiemeier, Henning
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2014, 23 (10) : 973 - 992
  • [47] Maternal aflatoxin exposure during pregnancy and adverse birth outcomes in Uganda
    Lauer, Jacqueline M.
    Duggan, Christopher P.
    Ausman, Lynne M.
    Griffiths, Jeffrey K.
    Webb, Patrick
    Wang, Jia-Sheng
    Xue, Kathy S.
    Agaba, Edgar
    Nshakira, Nathan
    Ghosh, Shibani
    MATERNAL AND CHILD NUTRITION, 2019, 15 (02):
  • [48] Vaginal discharge during pregnancy and associated adverse maternal and perinatal outcomes
    Khaskheli, Meharunnissa
    Baloch, Shahla
    Baloch, Aneela Sheeba
    Shah, Syed Ghulam Sarwar
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2021, 37 (05) : 1302 - 1308
  • [49] Aflatoxin Exposure during Pregnancy, Maternal Anemia, and Adverse Birth Outcomes
    Smith, Laura E.
    Prendergast, Andrew J.
    Turner, Paul C.
    Humphrey, Jean H.
    Stoltzfus, Rebecca J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 96 (04): : 770 - 776
  • [50] Maternal cannabis use in pregnancy and child neurodevelopmental outcomes
    Corsi, Daniel J.
    Donelle, Jessy
    Sucha, Ewa
    Hawken, Steven
    Hsu, Helen
    El-Chaar, Darine
    Bisnaire, Lise
    Fell, Deshayne
    Wen, Shi Wu
    Walker, Mark
    NATURE MEDICINE, 2020, 26 (10) : 1536 - +